Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1
Astilbin, as a compound of flavonoids, exerts anti-inflammation, antioxidation, and immune-suppression activities. Decreased activation of NF-κB and p38 MAPK and increased activation of SOCS3 and AMPK have been found in astilbin-treated cells. However, what molecules are docked by astilbin to initia...
Main Authors: | Shizhen Ding, Guotao Lu, Biying Wang, Jie Xiang, Chunxia Hu, Zhijie Lin, Yanbing Ding, Weiming Xiao, Weijuan Gong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.848957/full |
Similar Items
-
microRNA-144/451 decreases dendritic cell bioactivity via targeting interferon-regulatory factor 5 to limit DSS-induced colitis
by: Zhijie Lin, et al.
Published: (2022-07-01) -
Production of Taxifolin from Astilbin by Fungal Biotransformation
by: Jianfeng Mei, et al.
Published: (2022-09-01) -
Studies on the Anti-Gouty Arthritis and Anti-hyperuricemia Properties of Astilbin in Animal Models
by: Yan Han, et al.
Published: (2020-04-01) -
Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease
by: Wuyuntana Wang, et al.
Published: (2019-09-01) -
Astilbin Inhibits the Activity of Sortase A from <i>Streptococcus mutans</i>
by: Junxian Wang, et al.
Published: (2019-01-01)